UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Lawmaker motions bill for approving use of medical marijuana in Korea
A lawmaker has set out to revise the current laws against marijuana to allo...
by Marian Chu
|
2018-01-11 18:02
라인
Korean triplets born 2 months apart for 1st time, SNUH says
A 35-year-old Korean mother has given birth to triplets two months apart, t...
by Marian Chu
|
2018-01-11 17:06
라인
Daewoong gets approval to start Nabota BTX clinical trials in China
Daewoong Pharmaceutical is making inroads into the Chinese market with its ...
by Marian Chu
|
2018-01-11 16:24
라인
Drugmakers work on ‘me-too’ drugs of Pradaxa
Hanmi Pharmaceutical, Ahngook Pharmaceutical, Dasan Medichem, and Huons are...
by Lee Hye-seon
|
2018-01-11 16:12
라인
Hanmi slates US-based phase 1 trial for LAPSTriple Agonist: CEO
Hanmi Pharmaceutical is ramping up efforts to enter the global market with ...
by Marian Chu
|
2018-01-11 15:59
라인
Korean drugmakers promote pipelines at JP Morgan event
Korean pharmaceutical and biotech firms publicized their competitiveness, u...
by So Jae-hyeon
|
2018-01-11 15:42
라인
Drugmakers speed up ownership successions
Since the beginning of the New Year, pharmaceutical companies are accelerat...
by So Jae-hyeon
|
2018-01-11 12:01
라인
AstraZeneca gets go-ahead for biologic asthma drug in Europe
AstraZeneca and its global research and development subsidiary MedImmune sa...
by Marian Chu
|
2018-01-11 10:48
라인
Eli Lilly withdraws testosterone replacement therapy from Korea
Eli Lilly and Company has taken its topical testosterone replacement therap...
by Marian Chu
|
2018-01-10 17:11
라인
Public hearing to discuss support plans for healthcare industry
The Ministry of Health and Welfare (MOHW) said it would convene a public he...
by Lee Han-soo
|
2018-01-10 16:17
라인
Luxturna to open gene therapies market: analyst
The latest approval by the U.S. Food and Drug Administration for Luxturna, ...
by Nam Doo-hyun
|
2018-01-10 15:48
라인
Obstetrician in fetal death case not guilty
An obstetrics-gynecology clinic’s doctor, who received a jail term for an a...
by Choi Gwang-seok
|
2018-01-10 15:30
라인
Test for fetal sex chromosome defects wins patent
A local firm has won a patent in testing fetal sex chromosome abnormalities...
by Nam Doo-hyun
|
2018-01-10 14:39
라인
Drugmakers play it safe under ‘K-Sunshine Act’
Drugmakers are limiting salespersons’ use of corporate credit cards amid co...
by So Jae-hyeon
|
2018-01-10 14:23
라인
AbbVie’s atopic dermatitis drug designated ‘breakthrough therapy’
AbbVie Korea said Wednesday that upadacitinib, its investigational therapy ...
by Marian Chu
|
2018-01-10 14:13
라인
Vieworks unveils bio-imaging equipment
Vieworks, which specializes in medical imaging, said Wednesday that it has ...
by Lee Han-soo
|
2018-01-10 14:07
라인
U&I gets FDA nod for facet screw fixation system
U&I Corp. said Tuesday that it has received the U.S. Food and Drug Administ...
by Lee Han-soo
|
2018-01-10 10:25
라인
Rayence to set up production base in Brazil
Rayence, a Korean company, specializing in digital X-ray imaging solution, ...
by Lee Han-soo
|
2018-01-10 10:25
라인
Ministry orders recall on Israeli gel
The Ministry of Food and Drug Safety (MFDS) said Tuesday that it has ordere...
by Lee Han-soo
|
2018-01-09 17:52
라인
Seoul retains ban on prime-time junk food ads
Korea will indefinitely uphold its policy that bars television ads of unhea...
by Marian Chu
|
2018-01-09 17:20
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top